請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/44093
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 江文章 | |
dc.contributor.author | Pei-Fen Liao | en |
dc.contributor.author | 廖珮芬 | zh_TW |
dc.date.accessioned | 2021-06-15T02:39:37Z | - |
dc.date.available | 2014-08-19 | |
dc.date.copyright | 2009-08-19 | |
dc.date.issued | 2009 | |
dc.date.submitted | 2009-08-12 | |
dc.identifier.citation | 王璧娟,連塗發,陳秋霖,林高塚。2000。牛蒡對老鼠血糖、血脂及尿酸的影響。台灣農化學會與食品科學。38(2): 181-183。
王伯徹。2008。台灣商業化栽培食用菇類之特性與利用價值。食品工業。40(5): 16-18。 行政院衛生署國民健康局。2007。成人(20歲以上)代謝症候群之判定標準。 行政院衛生署。2009。中華民國97年國人十大死因統計資料。 何橈通。1986。糖尿病與公共衛生。臨床醫學。17: 300-317。 吳恭平。2001。健康粥。文經出版社。 吳宜娟。2001。薏仁加工產品對大白鼠脂質代謝之影響。國立台灣大學食品科技研究所碩士論文。台北。 吳崇榮。2004。自然醫學在第2型糖尿病治療中的角色扮演。自然醫學研究。1: 1-7。 呂鋒洲。1995。脂質過氧化之機轉生理意義及其定量。自由基生物學與醫學。3: 43-56。 杜姿瑩。1999。糙薏仁降血脂作用之研究。國立台灣大學食品科技研究所碩士論文。台北。 林進丁。1986。胰島素。藥學雜誌。2: 57-63。 邱智賢。2005。糖尿病與實驗動物模式的開發。生物產業。16(4): 288-298。 徐國鈞、何宏賢、徐珞珊、金蓉鸞。1996。中國藥材學。中國醫藥科技出版社。1156-1159。 區少梅。2003。食品感官品評學及實習。華格那。 陳正哲。1998。中草藥在抗氧化作用的測定。私立靜宜大學應用化學研究所碩士論文。台中。 陳世爵。豆腐-歷史悠久的保健食品。美國黃豆出口協會網站。 陳國榮。2003。腎臟移植患者消化性潰瘍的危險因子-單一醫學中心十一年的經驗。私立中山醫學大學醫學研究所碩士論文。台中。 楊莉君、陳美櫻、許文音、白永河、喻小珠、蔡敬民。1998。薏仁對高血脂病患血脂質及血糖的影響。食品科學。25: 727-736。 經濟部中央標準局。2006。中國國家標準 (CNS 15021 N6383):食品檢驗法-大豆異黃酮之測定。台灣。 趙盈鈞。2006。研發高價值雜糧加工產品計劃第一年成果報告。 潘恆嘉,黃國晉,陳慶餘。2004。胰島素阻抗與代謝症候群。基層醫學。21: 273-277。 劉伯康、陳惠英、顏國欽。1999。數種傳統食用植物甲醇萃取物抗氧化性之研究。中國農業化學會誌 37: 105-116。 劉桂萍。2000。薏苡殼甲醇萃取物清除自由基成分之分離與純化。國立台灣大學食品科技研究所碩士論文。台北。 錢阜甯。2009。肥胖與代謝症候群。食品工業。41(1): 62-69。 簡盟月、吳英黛。2006。胰島素阻抗與運動訓練的效果-細胞與分子層面之探討。物理治療。31: 130-141。 Alpaslan M and Hayta M. 2002. Hydration properties, soymilk and okara yield of soybean affected by agronomic factors. N-ahrung 46: 141-143. Alberti KGMM, Zimmet P, Shaw J. 2006. Metabolic syndrome—a new world wide definition. A consensus statement from the I-nternational Diabetes Federation.Diabet Med 23: 469–480. American Association of Cereal Chemists. 2001. The definiti- on of dietary fiber. Cereal Foods World 46: 112–129. Anugwa FOI, Varel VH, Dickson JS, Pond WG and Krook LP. 1989 . Effect of dietary fiber and protein concentration on grow-th, feed effecieny, visceral organ weights and large intens-tine microbial population of swine. J.Nutr 119: 879-886. Anderson JW, Allgood LD, Turner J, Oeltgen PR, Daggy BP.1990 . Effects of psyllium on glucose and serum lipid responses in men with type 2 diabete and hypercholesterolemia. Am J C-lin Nutr 70: 466-473. Aoki M and Tuzihara N. 1984. Effects of the hatomugi (Coix lachrymal-jobi L.var. ma-yuen) on the blood pressure,choles- terol adsorption and serum lipid level. Kaseigaku Zasshi 35: 89-96. Aoki M and Tuzihara N. 1985. Effects of the hatomugi (Coix lachrymal-jobi L.var. ma-yuen) on the hyperlipidemia in rats . Kaseigaku Zasshi 36: 27-33. Arts IC and Hollman PC. 2005. Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr 81: 317S-325S. Aronson D and Rayfield EJ. 2002. How hyperglycemia promotes atherosclerosis:molecular mechanisms. Cardiovasc Diabetol 8(1):1. Bantle JP, Laine DC, Castle GW, Thomas JW, Hoogwerf BJ, Goe- tz FC. 1983.Postprandial glucose and insulin responses to m-eals containing different carbohydrates in normal and diabe- tic subjects. N Engl J Med 309(1): 7-12. Balkau B and Charles MA. 1999.Comment on the provisional re- port from the WHO consultation.European Group for the Study of Insulin Resistance (EGIR). Diabet Med 16: 442–443. Bergmann JF, Chassany O, Pepit A, Triki R, Caulin C, Segres- taa JM. 1992. Correlation between echographic gastric empty-ing and appetite:influence of psyllium. Gut 33(8): 1042-1043 Bieger WP, Michel G, Barwich D, Biehl K, Wirth A. 1984. Dim- inished insulin receptors on monocytes and erythrocytes in hypertriglyceridemia.Metabolism 33: 982-987. Bosello O and Zamboni M. 2000. Visceral obesity and metabol- ic syndrome.Obes Rev 1: 47-56. Bos MJ, Koudstaal PJ, Hofman A, Witteman JC, Breteler MM. 2-006. Uric acid is a risk factor for myocardial infarction a- nd stroke:The Rotterdam study. Stroke 37: 1503-1507. Brownlee M. 2001. Biochemistry and molecular cell biology of diabetic compliations. Nature 414: 813-820. Cani PD, Dewever C, Delzenne NM. 2004. Inulin-type fructans modulate gastroint estinal peptides involved in apetite regulation, glucagon-like peptide-1,and ghrelin, in rats. Br J Nutr 92: 521-526. Cani PD, Neyrinck AM, Maton N, Delzenne NM. 2005. Oligofruc- tose promotes satiety in rats fed high-fat diet:involvement of glucagon-like peptide-1.Obes Res 13: 1000-1007. Cheung P.C.K. 1996. The hypocholesterolemic effects of two edible mushrooms: Auricularia auricular (tree-ear) and Trem- emella fuciformis (white Jelly-leaf) in hypercholesterolemi- c rats. Nutr Res 16: 1721-1725. Chibata I, Okumura K, Takeyama S, Kotera K. 1969. Lentinaci- n:a new hypochol esterlemic substance in Lentinus edodes. Christel QD, Bernard G, Jacques V, Thierry D, Claude B, Mic- hel L, Micheline C ,Jean-Cluade C, Francois B, Francis T. 2- 000. Phenolic compounds and antioxidant activities of buckw- heat (Fagopyrum esculentum Moench) hulls and flour. J Ethno- pharmacology 72: 35-42. Chung BS, Suzuki H, Hayakawa S, Kim JH, Nishizawa Y. 1988. Studies on the plasma cholesterol-lowering components in co- ix. Nippon Shokuhin Kogyo Gakkaishi 35: 618-623. Costacou T and Mayer-Davis EJ. 2003. Nutrition and preventi- on of type 2 diabetes. Annu Rev Nutr 23: 147-170. Conner EM and Grisham MB. 1996. Inflammation, free radicals, and antioxidants. Nutrition 12: 274-277. Crapo PA, Scarlett JA, Kolterman OG. 1982. Comparison of th- e metabolic responses to fructose and sucrose sweetened foo- ds. Am J Clin Nutr 36(2): 256-261. Day C. 2007. Metabolic syndrome, or what you will definitio- ns and epidemiology. Diab Vasc Dis Res 4(1): 32-38. Delbosc S, Paizanis E, Magous R, Araiz C, Dimo T, Cristol JP , Cros G, Azay J. 2005. Involvement of oxidative stress and NADPH oxidase activation in the development of cardiovascul- ar complications in a model of insulin resistance,the fruct- ose-fed rat. Atherosclerosis 179(1): 43-49. Ebihara K and Schneeman BO. 1989. Interaction of bile acids, phospholipids, cholesterol and triglyceride with dietary fi- bers in small intestine of rats. J Nutr 119: 1100-1106. Eckel RH, Grundy SM, Zimmet PZ. 2005. The metabolic syndrome .Lancet 365: 1415-1428. Esposito K, Pontillo A, Di Palo C, Giugliano F, Masella M,M-arfella R. 2003. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women. JAMA 289: 1799-1804. Facchini F, Chen YD, Hollenbeck CB, Reaven GM. 1991. Relati- onship between resistance to insulin-mediated glucose uptake , urinary uric acid clearance, and plasma uric acid concent- ration. JAMA 266: 3008-3011. Folch J, Less M, Sloane-Stanely GM. 1957. A simple method f- or isolation and purification of total lipids from animal t-issues. J Biol Chem 226: 497-509. Frayn K.N. 2000. Visceral fat and insulin resistance—causa- tive or correlative Br J Nutr 83: S71–S77. Galisteo M, Sanchez M, Vera R, Gonzalez M, Anguera A, Duarte J. 2005. A diet supplemented with husks of plantago ovata r-educes the development of endothelial dysfunction, hyperten- tion, and obesity by affecting adiponectin and TNF-alpha in obese Zucker rats. J Nutr 135: 2399-2404. Galisteo M, Duarte J, Zarzuelo A. 2008. Effects of dietary fibers on disturbances clustered in the metabolic syndrome. J Nutr Biochem. 19: 71-84. Golbitz P. 1995. Traditional soyfoods: processing and produ- cts. J Nutr 125: 570S-572S. Grarewal H.S. 1997. Antioxidants and diabetes prevention. C-RC press. New York 19-53. Grundy S.M. 2006. Drug therapy of the metabolic syndrome:mi- nimizing the emerging crisis in polypharmacy. Nat Rev Drug Discov 5: 295-309. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Fra- nklin BA. 2005. Diagnosis and management of the metabolic s-yndrome:an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112: 2735–2752. Hanai H, Ikuma M, Sato Y, Iida T, Hosoda Y, Matusushita I. 1997. Long-term effects of water-soluble corn bran hemicell- ulose on glucose tolerance in obese and non-obese patients: improved insulin sensitivity and glucose metabolism in obese subjects. Biosci Biotechnol Biochem 61: 1358-1361. Iwatani M, Wasada T, Katsumori K, Watanabe-Takahashi C, Kam- atani N,and Iwamoto Y. 2000. Troglitazone decreases serum u- ric acid concentrations in type II diabetes patients and no-n-diabetics. Diabetologia 43: 814-815. Jeon BS, Park JW, Kim BK, Kim HK, Jung TS, Hahm JR. 2005. F- ermented mushroom milk-supplemented dietary fiber prevents the onsets of obesity and hypertriglyceridaemia in Otsuka L- ong-Evans Tokushima fatty rats. Diabetes Obes Metab 7: 700-715. Jenkins DJA, Kendall CWC, Vuksan V. 2000. Viscous fibers, h- ealth claims, and strategies to reduce cardiovascular disea- se risk. Am J Clin Nutr 71: 401-402 Jimenez-Escrig A, Tenorio MD, Espinosa-Martos I, Ruperez P. 2008. Health-promoting effects of a dietary fiber concentra- te from the soybean byproduct okara in rats. J Argic Food C- hem. 56: 7495-7501. Kahn BB. 1996. Glucose transport: pivotal step in insulin a- ction. Diabetes 45: 1644-1654. Katayama M and Wilson LA. 2008. Utilization of okara, a byp-roduct from soymilk production, through the development of soy-based snack food. J Food Sci 73: S152-S157. Khosla NM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, Krotova K, Block ER, Prabhakar S, Johnson RJ. 2005. Hyperur- icemia induce endothelial dysfunction. Kidney Int 67: 1739-1742. Klevay L.M. 1975. Coronary heart disease: the zinc/copper h- ypothesis. Am J Clin Nutr 28: 764-774. Koh-Banerjee P and Rimm EB. 2003. Whole grain consumption a- nd weight gain:a review of the epidemiological evidence,pot- ential mechanisms and opportunities for future research. Pr- oc Nutr Soc 62: 25-29. Kok NN, Morgan LM, Williams CM, Roberfroid MB, Thissen JP, Delzenne NM. 1998. Insulin,glucagon-like peptide-1,glucose-dependent insulinotropic polypeptide and insulin-like growth factor I as putative mediators of the hypolipidemic effect of oligofructose in rats. J Nutr 128: 1099-1103. Kuan YH and Liong MT. 2008. Chemical and physicochemical ch- aracterization of agrowaste fibrous materials and residues. J Argic Food Chem 56: 9252-9257. Liu S, Willett WC, Manson JE, Hu FB, Rosner B, Colditz G. 2- 003. Relation between changes in intakes of dietary fiber a- nd grain products and changes in weight and development of obesity among middle-aged women. Am J Clin Nutr 78: 920-927. Li J, Wang J, Kanebo T, Qin LQ, Sato A. 2004. Effects of fi- ber intake on the blood pressure, lipids, and heart rate in Goto Kakizaki rats. Mutrition 20: 1003-1007. Matsumoto K, Watanabe Y, Yokoyama S. 2007. Okara,soybean re- sidue,prevent obesity in a diet-induced murine obesity model . Biosci Biotechnol Biochem 71: 720-727. Matsuo M. 2004. Saccharification of okara fiber by plant di-etary fiber hydrolases. J Nutr Sci Vitaminol 50: 291-294. Marlett JA, Burney MM, Slavin JL. 2002. Position of the Ame- rican Diatetic Association: health implications of dietary fiber. J Am Diet Assoc 102:993-1000. Masuo K, Kawaguchi H, Mikami H, Ogihara T, Tuck ML. 2003. S- erum uric acid and plasma norepinephrine concentrations pre- dict subsequent weight gain and blood pressure elevation. H-ypertension 42: 474-480. McKeown NM, Meigs JB, Liu S, Wilson PW, Jacques PF. 2002. W-hole-grain intake is favourably associated with metabolic risk factors for type 2 diabetes and cardiovascular disease in the Framingham Offspring Study. Am J Clin Nutr 76: 390–3 98. Nelson LH and Tucker LA. 1996. Diet composition related to body fat in a multivariate study of 293 men. J Am Diet Assoc 96: 771-777. Nakanishi N, Okamoto M, Yoshida H, Matsuo Y, Suzuki K, Tata- ra K. 2003. Serum uric acid and risk for development of hyp- ertention and impaired fasting glucose or type 2 diabetes in Japanese male office workers. Eur J Epidemiol 18: 523-530. Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushako- va O, Ouyang X, Feig DI, Block ER, Herrera-Acosta J, Patel JM, Johnson RJ. 2005. A causal role for uric acid in fructo- se-induced metabolic syndrome. Am J Physiol Renal Physiol 2- 90: F625-F631. Nabel E.G. 2003. Cardiovascular disease. N Engl J Med 349: 6 0-72. Ohkawa H, Ohishi N, Yagi K. 1979. Assay for lipid peroxides in animal tissue by thiobarbituric acid reaction. Anal Bioc- hem 95: 351-358. O'Toole D.K. 1999. Characteristics and use of okara,the soy- bean residue from soymilk production-a review. J Argic Food Chem 47: 363-371. Oron-Herman M, Kamari Y, Grossman E, Yeger G, Peleg E, Shab- tay Z, Shamiss A, Sharabi Y. 2008. Metabolic syndrome: comp- arison of the two commonly used animal models. Am J Hyperte-ns 21(9): 1018-1022. Pereira MA, Jacobs Jr DR, Pins JJ, Raatz SK, Gross MD, Slav- in JL. 2002. Effects of whole grain on insulin sensitivity in overweight hyperinsulinemic adults. Am J Clin Nutr 75: 84 8-855. Qi L, Rimm E, Liu S, Rifai N, Hu FB. 2005. Dietary glycemic index,glycemic load, cereal fiber, and plasma adiponectin c-oncentration in diabetic men. Diabetes Care 28(5): 1022-1028 Qi L, Meigs JB, Liu S, Manson JE, Mantzoros C, Hu FB. 2006. Dietary fibers and glycemic load,obesity,and plasma adipone- ctin levels in women with type 2 diabetes. Diabetes Care 29(7): 1501-1505. Ramos RR, Alarcon-Aguilar F, Lara-Lemus A, Flores-Saenz JL. 1992. Hypoglycemia effects of plants used in Mexico as anti-diabetics. Archives Med Res 23: 59-64. Reaven G.M. 1988. Role of insulin resistance in human disea- se. Diabetes 37(12): 1585-1607. Reaven G.M. 2000. Diet and syndrome X. Curr Atheroscler Rep 2: 503–507. Ripsin CM, Keenan JM, Jacobs Jr DR, Elmer PJ, Welch RR, Van Horn L. 1992. Oat products and lipid lowering. A meta-analy- sis. JAMA 267: 3317-3325. Saltiel AR and Kahn CR. 2001. Insulin signaling and the reg- ulation of glucose and lipid metabolism. Nature 414: 799-806 Schneeman B.O. 2002. Gastrointestinal physiology and functi- ons.Br J Nutr 88(2): S159-S163. Sierra M, Garcia JJ, Fernandez N, Diez MJ, Calle AP, Sahagu- n AM. 2001. Effects of ispaghula husk and guar gum on postp- randial glucose and isulin concentrations in health subjects . Eur J Clin Nutr 55: 235-243. Sierra M, Garcia JJ, Fernandez N, Diez MJ, Calle AP, Farmaf- ibra Group. 2002. Therapeutic effects on psyllium in type 2 diabetic patients. Eur J Clin Nutr 56: 830-842. Slavin J.L. 2005. Dietary fiber and body weight. Nutrition 2 1: 411-418. Stirpe F, Della Corte F, Bonetti E, Abbondanza A, Abbati A, De Stefano F. 1970. Fructose-induced hyperuricaemia. Lancet 2: 1310-1311. Takahashi M, Konno C, Hikino H. 1986. Isolation and hypogly- cemic activity of coixans A, B and C, glycans of Coix lachr- ymal-jobi var. ma-yuen seed. Planta Med 52: 64-65. Thorburn AW, Storlien LH, Jenkins AB, Khouri S, and Kraegen EW. 1989. Fructose-induced in vivo insulin resistance and e-levated plasma triglyceridelevels in rats. Am J Clin Nutr 49 : 1155-1163. Toda K, Chiba K, Ono T. 2007. Effects of components extract-ed from okara on the physicochemical properties of soymilk and tofu texture. J Food Sci 72: C108-C113. Tsunoda S, Kamide K, Minami J, Kawano Y. 2002. Decreases in serum uric acid by amelioration of insulin resistance in ov- erweight hypertensive patients: effect of low-energy diet a-nd an insulin-sensitizing agent. Am J Hypertens 15: 697-701. Ukkol O and Bouchard C. 2001. Clustering of metabolic abnor-malities in obese individuals:the role of genetic factors. Ann Med 33: 79–90. Weickert MO and Pfeiffer AF. 2008. Metabolic effects of die- tary fiber consumption and prevention of diabetes. J Nuti 13 8: 439-442. Wakui A, Kasai M, Konno K, Abe R, Kanamaru R, Takahashi K, Nakai Y, Yoshida Y, Koie H, Masuda H. 1986. Randomized study of lentinan on patients with advanced gastric and colorectal cancer. Tohoku Lentinan Study Group Gan To Kagaku Ryoho 13(4 Pt 1): 1050-1059. Zavaroni I, Sander S, Scott S, Reaven GM. 1980. Effect of f- ructose feeding on insulin secretion and insulin action in the rat. Metabolism 29(10): 970-973. Zavaroni I, Chen YI, Reaven GM. 1982. Studies od mechanism of insulin-induced hypertriglyceridemia in the rat.Metaboli- sm 31: 1077-1083. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/44093 | - |
dc.description.abstract | 代謝症候群是近年來極受到重視的健康議題,其症狀包括腹部肥胖、高胰島素血症、血脂異常和高血壓等,此些危險因子的聚集現象與心血管疾病及第二型糖尿病有密切的相關性。日常生活中,可藉由控制飲食和運動來改善代謝症候群,以降低這些危險因子。而在預防代謝症候群方法上,以飲食控制最為重要,若是我們可研發一保健食品具有調節代謝症候群的作用,將會有許多人受益。
豆渣乃指黃豆經由萃取豆奶後,所殘留下的殘渣部份,傳統上往往被當作寵物食品或是廢棄物丟棄。然而豆渣富含許多高品質蛋白質、膳食纖維和植物化學物質等成分,因為豆渣的特別成分,值得將其應用於食品中。薏苡(Coix lachrymal-jobi L.var. ma-yuen Stapf )自古以來即為食藥兩用之材料,許多研究均顯示其具有調節血脂及血糖等生理功效。因此本研究之目的可分為兩部份,第一部份為設計黃豆渣與薏苡之不同配方產品,進行感官品評篩選出較佳產品;第二部份為利用餵食高果糖誘發大鼠產生代謝症候群,探討產品之功效。 實驗第一階段為設計不同配方產品。將豆渣以10%至45%的比例取代於糙薏仁及白米中,製成產品並進行感官品評,結果發現,當糙薏仁與豆渣比例為8:5時,產品無論風味或是對豆渣喜好度皆較佳。實驗第二階段進一步探討產品功效,和給予高果糖飼料組(HF)相比,給予一包產品取代高果糖飼料之低劑量組(L)及給予兩包產品取代高果糖飼料之高劑量組(H)皆能顯著降低血漿中三酸甘油酯濃度、極低密度脂蛋白三酸甘油酯(VLDL-TG)及尿酸濃度(p<0.05)。綜合上述,我們將豆渣成功應用於產品,不但消費者喜好度佳,藉由動物實驗也證實產品可有效降低血漿中三酸甘油酯、尿酸濃度。 | zh_TW |
dc.description.abstract | Metabolic syndrome (MS) is defined by the cluster of physiologic and metabolic abnormalities, including overall and central obesity, hyperinsulinemia, dyslipidemia and hypertension. And it will increase the probably of cardiovascular disease and type 2 diabetes. In daily life, we can lose weight by food control and exercise to improve MS and lower the risk factors of diseases. Above all, food control is the most important. Therefore, if we can develop a functional food with effect on ameliorating metabolic syndrome, there will be a lot of people benefit from this product.
Okara is the residue obtained from soybeans after extracting soymilk and traditionally used as animals’ food or burnt as waste. However, okara is rich in high-quality proteins, dietary fiber and phytochemicals. Due to these peculiar compositions, it might have the potential to use in the food industry. Dehulled adlay has been used as a medical herb substance and functional food for traditional treatment of diabetes in China. Many studies indicate that adlay play an important role in the regulation of plasma lipids and glucose metabolisms. Therefore, the aims of this study can divide into two parts. The first part, we design a product containing okara, dehulled adlay and other ingredients in different proportion. By the way of sensory evaluation, we select the final product. The second part, we will evaluate the effect of okara and adlay processing food on metabolic syndrome induced by high fructose diet in rats. The first stage of this study was to design the products in different ratios of the materials. We made the products by taking the place of dehulled adlay and rice with 10% to 45% of okara. According to the results of sensory evaluation, we found that when the ratio of dehulled adlay and okara was 8:5, the flavor and okara feeling were best. The second stage of this study was to investigate the effect of product on rats with metabolic syndrome. Comparing with the group HF (fed with high fructose diet), group L (high fructose diet was replaced with one product) and group H(high fructose diet was replaced with two products) could lower the serum triglyceride and uric acid levels significantly. To summarize, we made the okara in the products successfully, and the products can lower serum triglyceride and uric acid levels significantly by animal experiment. | en |
dc.description.provenance | Made available in DSpace on 2021-06-15T02:39:37Z (GMT). No. of bitstreams: 1 ntu-98-R96641017-1.pdf: 1437695 bytes, checksum: f026d23cbe06796008d837dceee38ea1 (MD5) Previous issue date: 2009 | en |
dc.description.tableofcontents | 目錄
中文摘要......................................I 英文摘要.....................................II 目錄........................................ III 表目錄.......................................VI 圖目錄.......................................VII 壹、前言.................................... 1 貳、文獻回顧................................ 2 第一節、材料特性.............................2 一、糙薏仁...................................2 二、黃豆與黃豆渣......................... 4 第二節、感官品評.............................7 一、感官品評定義............................ 7 二、感官品評方法..............................7 三、感官品評之消費者型試驗...................7 第三節、代謝症候群...................8 一、代謝症候群之簡介...........................8 二、代謝症候群之定義及診斷標準.................8 三、代謝症候群與肥胖...........................10 四、代謝症候群與心血管疾病............10 第四節、胰島素...............................14 一、胰島素簡介............................ 14 二、胰島素接受器.......................... 14 三、胰島素與醣類代謝...........................15 四、胰島素與脂質代謝...................................16 五、胰島素與蛋白質代謝...............................16 六、胰島素阻抗.................................. 16 第五節、高血糖與氧化壓力............................. 17 一、高血糖與氧化壓力................17 二、體內抗氧化防禦系統及外源性抗氧化物質..................19 第六節、膳食纖維..........................21 一、膳食纖維定義........................... 21 二、膳食纖維之分類與來源...............21 三、膳食纖維與肥胖............................21 四、膳食纖維與高血糖/胰島素抗性.......................22 五、膳食纖維與血脂異常.......................... 22 第七節、高果糖誘導代謝症候群之動物模式.............. 24 一、高果糖動物模式....................... 24 二、果糖與脂質代謝...........................24 三、果糖與高尿酸血症........................ 24 參、研究目的與實驗架構.......................26 一、研究目的.................................26 二、實驗架構........................... 27 (一) 整體架構............................... 27 (二) 糙薏仁及豆渣比例設計...................28 (三) 動物實驗........................... 29 肆、材料與方法..............................30 第一節、實驗材料與儀器設備..................30 一、實驗材料................................30 二、化學藥品與試劑..........................30 (一) 化學藥品...............................30 (二) 溶劑................................. 30 (三) 商業酵素套組...........................30 (四) 動物飼料組成...........................31 三、儀器設備................................ 31 (一) 用於原料及產品基本成分分析............ 31 (二) 用於產品機能性成分分析.................32 (三) 用於動物飼料配製.......................32 (四) 用於動物實驗樣品分析...................32 第二節、實驗方法............................33 實驗I:設計配方並用感官品評選出消費者喜好度較佳之糙薏仁及豆渣加工產品...................33 一、濕豆渣一般組成分分析....................33 (一) 水分測定...............................33 (二) 灰份測定...............................33 (三) 粗蛋白測定.............................34 (四) 粗脂肪測定………………………………... 34 (五) 膳食纖維測定...........................34 二、豆渣取代量之設計與選擇..................36 三、感官品評................................37 四、產品之基本成分分析……………………………37 五、產品之機能性成分分析....................37 (一) 異黃酮含量測定.........................37 (二) 類黃酮含量測定......................... 37 實驗II:探討餵食以產品取代部分飼料10週對高果糖餵飼大鼠模式誘發代謝症候群之影響..........................38 一、實驗動物................................38 二、動物分組與飼養..........................38 三、禁食狀態血液之採集與處理................39 四、動物犧牲與檢體之收集與分析..............39 (一) 動物檢體收集與處理................... 39 (二) 動物犧牲後之生化分析項目...............40 1. 血液之生化值分析.........................40 2. 肝臟之生化值分析.........................42 3. 糞便之生化值分析………………………. 43 第三節、統計方法............................44 伍、結果與討論.............................45 實驗I:設計配方並用感官品評選出消費者喜好度較佳之糙薏仁及豆渣加工產品...................................45 一、未乾燥豆渣之水分含量及乾燥後的豆渣之基本成…45 二、配方設計及改良…………………………………….45 三、感官品評..................................46 四、產品之基本組成.......................... 46 實驗II:探討餵食以產品取代部分飼料10週對高果糖餵飼大鼠模式誘發代謝症候群之影響.............................. 55 一、結果............................................ 55(一) 生長狀況與飼料利用率..........................55 (二) 組織臟器重量...............................55 (三) 血液生化值分析.............................55 (四) 肝臟脂質分析.............................56 (五) 糞便脂質分析……………………………………56 (六) 氧化指標分析............................56 二、討論………………………………………………57 (一) 高果糖動物模式.........................57 (二) 生長狀況與飼料利用率..................57 (三) 組織臟器重量………………………………..57 (四) 高三酸甘油酯血症....................57 (五) 高膽固醇血症........................58 (六) 高尿酸血症........................58 (七) 高血糖與胰島素濃度................58 (八) 氧化壓力..........................59 陸、結論................................60 柒、參考文獻............................71 | |
dc.language.iso | zh-TW | |
dc.title | 開發糙薏仁及豆渣加工產品及其對高果糖誘發代謝症
候群大鼠之機能性研究 | zh_TW |
dc.title | Development of the product of dehulled adlay and okara processing food and study its effect on metabolic syndrome in fructose-fed rats | en |
dc.type | Thesis | |
dc.date.schoolyear | 97-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 盧義發,江孟燦,鄭心嫻,蔡震壽 | |
dc.subject.keyword | 豆渣,糙薏仁,膳食纖維,高果糖,飲食,代謝症候群, | zh_TW |
dc.subject.keyword | okara,dehulled adlay,dietary fiber,high fructose diet,metabolic syndrome, | en |
dc.relation.page | 79 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2009-08-12 | |
dc.contributor.author-college | 生物資源暨農學院 | zh_TW |
dc.contributor.author-dept | 食品科技研究所 | zh_TW |
顯示於系所單位: | 食品科技研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-98-1.pdf 目前未授權公開取用 | 1.4 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。